2015, Number 1
<< Back Next >>
Rev Biomed 2015; 26 (1)
Hearth transplants for chagas disease in Mexico
Lozano-Kasten F, Soto-Gutiérrez M, Magallón-Gastélum E, Kasten- Monges M, Hinojosa-Alarcón F, Peregrina-Lucano AA
Language: Spanish
References: 14
Page: 41-45
PDF size: 115.61 Kb.
ABSTRACT
The aim of this report is to present the clinical,
surgical, paraclinical, therapeutical and
epidemiological data supporting the first heart transplant case related to Chagas disease in
Mexico. The subject, a 35 year old male, was diagnosed with a dilated cardiomyopathy unable
to support life. Serological testing was completed,
and
T. cruzi isolated after a surgical intervention
due to post operatory complications to the transplant. Nine years after transplantation, the
patient was considered cured and re-entered the
labor force. Patients clinically diagnosed with
dilated cardiomyopathy and positive serology
for
T. cruzi, are frequent, representing 15% in
the country. The presence of this case and its diagnostic circumstances indicates the existence
of a greater number of already transplanted
undiagnosed cases in the country. Therefore it is necessary to recognize the role of Chagas disease in heart transplantation candidates due to dilated
cardiomyopathy.
REFERENCES
Sierra-Johnson J, Olivera-Mar A, Monteón-Padilla Victor M, Reyes Pedro A, Vallejo M. Panorama epidemiológico y clínico de la cardiopatía chagásica en México. Rev. Saúde Pública. 2005; 39 (5): 754-60.
Dumonteil E. Update on Chagas disease in Mexico. Salud Pública Méx 1999; 41: 322-327.
Alducin-Téllez, César et al. Prevalencia de serología positiva para Trypanosoma cruzi en pacientes con diagnóstico clínico de miocardiopatía dilatada en el Estado de Campeche, México. Arch. Cardiol. Méx., 2011; 81 (3): 204-207.
Martínez Gutiérrez, E. et al. Experiencia con trasplante cardiaco: Hospital General Centro Médico Nacional “La Raza”, IMSS. Cirujano General. 2002; 24 (2): 140-143.
Fiorelli AI, et al. Trasplante cardiaco en pacientes con enfermedad de Chagas. Experiencia de un único centro. Cirugía Cardiovascular. 2011; 18(3): 225–232.
Kransdorf EP, et al. Heart transplantation for Chagas cardiomyopathy in the United States. Am J Transplant. 2013; 13(12):3262-3268.
Cerisola JA. Chemotherapy of Chagas infection in man. Scientific Publication, PAHO 1977; N° 347.
Mota JD, Suárez C, García J. Biopsia endomiocárdica en miocarditis chagásiga e inespecífica. Gac Méd Caracas 1998;106(3):358-368.
Secretaría de Salud, Reglamento del Consejo Nacional de Trasplantes http://www.cenatra.salud. gob.mx/interior/sistema_nacional_consejo_nacional. html. 2014.
Fiorelli AI, Santos RH, Oliveira JL Jr, Lourenço- Filho DD, Dias RR, Oliveira AS, et al. Hearth transplantation in 107 cases of Chagas´ disease. Transplant Proc. Jan-Feb. 2011;43(1):220-4
Bocchi EA, Bellotti G, Mocelin AO, et al. Heart transplantation for cronic Chagas´ heart DISEASE. Ann Thorac Surg. Jun 1996;61:1727-33.
Campos SV, Strabelli TM, Amato Neto V, et al. Risk factors for Chagas´ disease reactivation after heart transplantation. J. Heart Lung Transplant. Jun 2008;27(6):597-602.
Bacal F, Silva CP, Pires PV, Mangini S, Fiorelli AI, Stolf NG, et al. Transplantation for Cagaas´disease: an overview of immunosuppression and reactivación in the last two decades. Clinc Transplant. Mar-Apr 2010;24(2):29-34.
Secretaría de Salud. Centro Nacional de Trasplantes. Informe Anual 2013. Disponible en www.salud.gob. mx/unidades/cdi/nom/compi/ReinCNT.html
Full text